1 July 2025

Last updated: Friday 27 June 2025

Research Directory

EU public policy on AI

Stock Market Performance: Dismal Q1 for European biotechs

BioPharma updates 2025 forecasts with some cautions

Antimicrobial Review: Drug-resistant infections are the silent pandemic

Interview with MoonLake: Exploiting the potential of a single biologic

Oncology Review: New targets for challenging diseases

European biotech: Marching forward into 2025

The ethics of gene editing- conference presentation Mar 2025

Moving beyond the amyloid beta hypothesis, by Jean-Claude Muller

Trends in investment for cell and gene therapies